M 150 Pill - brown three-sided, 11mm
Generic Name: momelotinib
Pill with imprint M 150 is Brown, Three-sided and has been identified as Ojjaara 150 mg. It is supplied by GlaxoSmithKline.
Ojjaara is used in the treatment of Myelofibrosis and belongs to the drug class multikinase inhibitors. Ojjaara 150 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for M 150
Ojjaara
- Generic Name
- momelotinib
- Imprint
- M 150
- Strength
- 150 mg
- Color
- Brown
- Size
- 11.00 mm
- Shape
- Three-sided
- Availability
- Prescription only
- Drug Class
- Multikinase inhibitors
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- GlaxoSmithKline
- National Drug Code (NDC)
- 81864-0102
Related images for "M 150"
More about Ojjaara (momelotinib)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: multikinase inhibitors
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
